Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 12/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | PTGDR | Q13258 | 5/20 | 0.34 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.34 |
| ▸ | MPO | P05164 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6152396 | 0.90 | NOS3 (0.43) | NOS3NOS1NOS2KDM4E | |
| SCHEMBL6155624 | 0.89 | NOS3 (0.43) | NOS3NOS1NOS2 | |
| SCHEMBL6152762 | 0.85 | NOS3 (0.46) | NOS3NOS1NOS2 | |
| SCHEMBL6152658 | 0.82 | NOS3 (0.68) | NOS3NOS1NOS2KDM4E | |
| SCHEMBL6153073 | 0.80 | NOS3 (0.47) | NOS3NOS1NOS2PTGDR2KDM4E | |
| SCHEMBL5833906 | 0.80 | NOS3 (0.44) | NOS3NOS1NOS2PTGDR2KDM4E | |
| SCHEMBL6152641 | 0.80 | NOS3 (0.38) | NOS3NOS1NOS2 | |
| SCHEMBL6153072 | 0.75 | NOS3 (0.42) | NOS3NOS1NOS2PTGDR2KDM4E | |
| SCHEMBL6152398 | 0.70 | NOS3 (0.45) | NOS3NOS1NOS2KDM4E | |
| SCHEMBL5833973 | 0.70 | NOS3 (0.42) | NOS3NOS1NOS2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1084109-B1 | 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NITRIC OXIDE SYNTHASE INHIBITORS | PFIZER PROD INC (US) | 2005-01-26 | — | — | EP | disclosed |
| EP-1494680-A1 | USE OF CARBON-2-MODIFIED-VITAMIN D ANALOGS TO INDUCE THE FORMATION OF NEW BONE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003082300-A1 | USE OF CARBON-2-MODIFIED-VITAMIN D ANALOGS TO INDUCE THE FORMATION OF NEW BONE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2003-10-09 | — | — | WO | disclosed |
| EP-1268415-A1 | 26,27-HOMOLOGATED-20-EPI-2-ALKYL-19-NOR-VITAMIN D COMPOUNDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001074765-A1 | 26,27-HOMOLOGATED-20-EPI-2-ALKYL-19-NOR-VITAMIN D COMPOUNDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2001-10-11 | — | — | WO | disclosed |
| EP-1084109-A1 | 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NITRIC OXIDE SYNTHASE INHIBITORS | Pfizer Products Inc. (US) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999062883-A1 | 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NITRIC OXIDE SYNTHASE INHIBITORS | PFIZER PRODUCTS INC. (US) | 1999-12-09 | — | — | WO | disclosed |